Registration

Join us for the next VJHemOnc Myeloma Session where UK myeloma experts Graham Jackson & Rakesh Popat will be reviewing their key highlights from ASH 2021 and what the latest breakthroughs mean for the clinic. They’ll be covering ISTOPP, frontline studies including OPTIMUM, MASTER and GRIFFIN, the latest exciting data in CAR-T, bispecifics and other novel therapies, as well as research…

Read the full article here

Related Articles